TABLE 1.
Characteristics | Summary statistics | |
---|---|---|
Age, mean ± (SD) (years) | 57.78 (±13.9) | |
Weight, mean ± (SD) (kg) | 84.39 (±21.8) | |
CrCl at enrollment, mean ± (SD) (mL/min) | 90.88 (±51.4) | |
Race, n (%) | White | 72 (92.3) |
Other | 6 (7.7) | |
Sex, n (%) | Female | 38 (48.7) |
Male | 40 (51.3) | |
ICU unit, n (%) | CVICU | 32 (41) |
MICU | 25 (32.1) | |
SICU | 21 (26.9) | |
BMI, n (%) | Normal or Underweight a (BMI <25) | 24 (30.8) |
Overweight (BMI between 25 to 30) | 23 (29.5) | |
Obese (BMI ≥30) | 31 (39.7) | |
Admitted to ICU after surgery, n (%) | 37 (47.4) | |
Baseline RASS measurement, median [IQR] | −3.00 [−4, −2] | |
Total number of RASS measurements | 1673 | |
Total number of RASS measurements recorded while receiving fentanyl, propofol, and/or midazolam | 1447 |
Abbreviations: BMI, body mass index; CrCl, creatinine clearance; CVICU, cardiovascular ICU; ICU, intensive care unit; IQR, interquartile range; MICU, medical ICU; PGx, pharmacogenomic; RASS, Richmond Agitation‐sedation scale; SD, standard deviation; SICU, surgical ICU.
One participant was underweight and was merged with the normal weight group.